The endothelin A receptor antagonist BQ 123 reduces BP levels, especially in patients with type 2 diabetes mellitus,

2006 ◽  
Vol &NA; (1563) ◽  
pp. 19
Author(s):  
&NA;
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Receptor Antagonist ◽  
Endothelin A Receptor ◽  
Endothelin A

Glucagon Receptor Antagonist LGD-6972 Significantly Lowers HbA1c and Is Well Tolerated after 12-Week Treatment in Patients with Type 2 Diabetes Mellitus (T2DM) on Metformin

Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 73-OR ◽  
Author(s):  
JEREMY PETTUS ◽  
ERIC G. VAJDA ◽  
JAMES PIPKIN ◽  
GRETCHEN WILLIAMSON ◽  
MIRIAM A. ZANGMEISTER ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Receptor Antagonist ◽  
Glucagon Receptor ◽  
Glucagon Receptor Antagonist

Gender-based dimorphic pattern for interleukin-1 receptor antagonist in type 2 diabetes mellitus

2008 ◽  
Vol 34 (1) ◽  
pp. 75-81 ◽  
Author(s):  
J. Ybarra ◽  
T.N.O. Lehmann ◽  
A. Golay ◽  
C.E. Juge-Aubry ◽  
P. Roux-Lombard ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Receptor Antagonist ◽  
Interleukin 1 ◽  
Interleukin 1 Receptor Antagonist ◽  
Gender Based
Sign in / Sign up

Export Citation Format

Share Document